litlas
ログインアカウント作成

Isabelle Rivière

1995–2025 年に発表

72
論文数
24,677
被引用数
57
h 指数
70
i10 指数

被引用数

Isabelle Rivière の年別被引用数1991 年: 被引用 2 件1992 年: 被引用 2 件1994 年: 被引用 1 件1996 年: 被引用 6 件1997 年: 被引用 12 件1998 年: 被引用 5 件1999 年: 被引用 16 件2000 年: 被引用 23 件2001 年: 被引用 15 件2002 年: 被引用 23 件2003 年: 被引用 31 件2004 年: 被引用 56 件2005 年: 被引用 57 件2006 年: 被引用 33 件2007 年: 被引用 57 件2008 年: 被引用 54 件2009 年: 被引用 71 件2010 年: 被引用 90 件2011 年: 被引用 95 件2012 年: 被引用 102 件2013 年: 被引用 234 件2014 年: 被引用 190 件2015 年: 被引用 331 件2016 年: 被引用 349 件2017 年: 被引用 385 件2018 年: 被引用 527 件2019 年: 被引用 1,185 件2020 年: 被引用 1,388 件2021 年: 被引用 1,436 件2022 年: 被引用 1,144 件2023 年: 被引用 1,079 件2024 年: 被引用 1,539 件2025 年: 被引用 804 件2026 年: 被引用 34 件1993 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,619 件、この内訳の 35%中国: 引用元論文 1,464 件、この内訳の 14.2%ドイツ: 引用元論文 657 件、この内訳の 6.4%イギリス: 引用元論文 505 件、この内訳の 4.9%イタリア: 引用元論文 401 件、この内訳の 3.9%フランス: 引用元論文 350 件、この内訳の 3.4%カナダ: 引用元論文 269 件、この内訳の 2.6%スペイン: 引用元論文 241 件、この内訳の 2.3%オーストラリア: 引用元論文 212 件、この内訳の 2.1%オランダ: 引用元論文 205 件、この内訳の 2%スイス: 引用元論文 200 件、この内訳の 1.9%日本: 引用元論文 200 件、この内訳の 1.9%
0%35%その他 19.4%

機関

分野

  • Medicine77.8%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Immunology and Microbiology7.9%
  • Engineering1.3%
  • Neuroscience0.6%
  • Materials Science0.3%
  • その他0.6%

トピック

  • CAR-T cell therapy research24.9%
  • Virus-based gene therapy research7.6%
  • Immune Cell Function and Interaction7.2%
  • Immunotherapy and Immune Responses6%
  • Nanowire Synthesis and Applications5.1%
  • Viral Infectious Diseases and Gene Expression in Insects3.8%
  • その他45.4%

共著者

全論文

検索で開く
  1. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

    著者: Jae H. Park, Isabelle Rivière, Mithat Gönen, Xiuyan Wang, Brigitte Sénéchal, Kevin J. Curran, Craig S. Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead, Mikhail Roshal, P. Maslak, Marco L. Davila, Renier J. Brentjens, Michel Sadelain - New England Journal of Medicine 2018 被引用: 2,675

  2. The Basic Principles of Chimeric Antigen Receptor Design

    著者: Michel Sadelain, Renier J. Brentjens, Isabelle Rivière - Cancer Discovery 2013 被引用: 1,498

  3. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

    著者: Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill, Amy Zhu, Waseem Cheema, Navin K. Chintala, Elizabeth Halton, John Pineda, Rocío Pérez-Johnston, Kay See Tan, Bobby Daly, Jose A. Araujo Filho, Daniel Ngai, Erin McGee, A. Vincent, Claudia Diamonte, Jennifer L. Sauter, Shanu Modi, Devanjan Sikder, Brigitte Sénéchal, Xiuyan Wang, William D. Travis, Mithat Gönen, Charles M. Rudin, Renier J. Brentjens, David R. Jones, Michel Sadelain - Cancer Discovery 2021 被引用: 560

  4. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

    著者: Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Shirley Bartido, Jae H. Park, Kevin J. Curran, Stephen S. Chung, Jolanta Stefanski, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Qing He, Mitsú J. Fink, Himaly Shinglot, Maher Youssif, Mark Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, Elizabeth Halton, Yvette Bernal, Diana Bouhassira, Maria E. Arcila, Mithat Gönen, Gail J. Roboz, P. Maslak, Dan Douer, Mark G. Frattini, Sergio Giralt, Michel Sadelain, Renier J. Brentjens - Science Translational Medicine 2014 被引用: 2,497

  5. GPRC5D-Targeted CAR T Cells for Myeloma

    著者: Sham Mailankody, Sean M. Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J. Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xiuyan Wang, Devanjan Sikder, Brigitte Sénéchal, Vladimir P. Bermudez, Terence J. Purdon, Kinga Hosszu, Devin McAvoy, Tasmin Farzana, Elena Mead, Jessica Wilcox, Bianca Santomasso, Gunjan L. Shah, Urvi A. Shah, Neha Korde, Alexander M. Lesokhin, Carlyn Tan, Malin Hultcrantz, Hani Hassoun, Mikhail Roshal, Filiz Şen, Ahmet Doǧan, Ola Landgren, Sergio Giralt, Jae H. Park, Saad Z. Usmani, Isabelle Rivière, Renier J. Brentjens, Eric L. Smith - New England Journal of Medicine 2022 被引用: 384

  6. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

    著者: Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu, Sjoukje J. C. van der Stegen, Theodoros Giavridis, Jorge Mansilla‐Soto, Justin Eyquem, Zeguo Zhao, Benjamin M. Whitlock, Matthew M. Miele, Zhuoning Li, Kristen Cunanan, Morgan Huse, Ronald C. Hendrickson, Xiuyan Wang, Isabelle Rivière, Michel Sadelain - Nature 2019 被引用: 665

  7. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

    著者: Bianca Santomasso, Jae H. Park, Darin Salloum, Isabelle Rivière, Jessica Flynn, Elena Mead, Elizabeth Halton, Xiuyan Wang, Brigitte Sénéchal, Terence J. Purdon, Justin R. Cross, Hui Liu, Behroze Vachha, Xi Chen, Lisa M. DeAngelis, Daniel Li, Yvette Bernal, Mithat Gönen, Hans-Guido Wendel, Michel Sadelain, Renier J. Brentjens - Cancer Discovery 2018 被引用: 924

  8. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

    著者: Renier J. Brentjens, Marco L. Davila, Isabelle Rivière, Jae H. Park, Xiuyan Wang, Lindsay G. Cowell, Shirley Bartido, Jolanta Stefanski, Clare Taylor, Malgorzata Olszewska, Oriana Bórquez-Ojeda, Jinrong Qu, Teresa Wasielewska, Qing He, Yvette Bernal, Ivelise Rijo, Cyrus V. Hedvat, Rachel Kobos, Kevin J. Curran, Peter G. Steinherz, Joseph G. Jurcic, Todd Rosenblat, P. Maslak, Mark G. Frattini, Michel Sadelain - Science Translational Medicine 2013 被引用: 2,077

  9. Therapeutic T cell engineering

    著者: Michel Sadelain, Isabelle Rivière, Stanley R. Riddell - Nature 2017 被引用: 898

  10. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

    著者: Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John Slingerland, Silvia Beghi, Pamela S. Herrera, Paul A. Giardina, Annelie Clurman, Emmanuel Agyemang Dwomoh, Gabriel K. Armijo, Antonio L. C. Gomes, Eric R. Littmann, Jonas Schlüter, Emily Fontana, Ying Taur, Jae H. Park, Maria Lia Palomba, Elizabeth Halton, Josel D. Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel‐Angel Perales, Craig W. Freyer, Alfred L. Garfall, Shannon Gier, Sunita D. Nasta, Daniel J. Landsburg, James N. Gerson, Jakub Svoboda, Justin R. Cross, Elise A. Chong, Sergio Giralt, Saar Gill, Isabelle Rivière, David L. Porter, Stephen J. Schuster, Michel Sadelain, Noelle V. Frey, Renier J. Brentjens, Carl H. June, Eric G. Pamer, Jonathan U. Peled, Andrea Facciabene, Marcel R.M. van den Brink, Marco Ruella - Nature Medicine 2022 被引用: 309

  11. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

    著者: John Maher, Renier J. Brentjens, Gertrude Gunset, Isabelle Rivière, Michel Sadelain - Nature Biotechnology 2002 被引用: 1,019

  12. GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells

    著者: Eric L. Smith, Kim Harrington, Mette Stæhr, Reed Masakayan, Jon C. Jones, Thomas J. Long, Khong Y. Ng, Majid Ghoddusi, Terence J. Purdon, Xiuyan Wang, Trevor Do, Minh Thu Pham, Jessica M. Brown, Carlos Fernández de Larrea, Eric J. Olson, Elizabeth Peguero, Pei Wang, Hong Liu, Yiyang Xu, Sarah C. Garrett-Thomson, Steven C. Almo, Hans‐Guido Wendel, Isabelle Rivière, Liu C, Blythe Sather, Renier J. Brentjens - Science Translational Medicine 2019 被引用: 385

  13. CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

    著者: Jae H. Park, Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah, Parastoo B. Dahi, Richard J. Lin, Michael Scordo, Miguel‐Angel Perales, Roni Shouval, Ana Alarcón Tomás, Elizabeth Cathcart, Elena Mead, Bianca Santomasso, Andrei I. Holodny, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain - Nature Medicine 2023 被引用: 164

  14. Clinical manufacturing of CAR T cells: foundation of a promising therapy

    著者: Xiuyan Wang, Isabelle Rivière - Molecular Therapy — Oncolytics 2016 被引用: 629

  15. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

    著者: Renier J. Brentjens, Isabelle Rivière, Jae H. Park, Marco L. Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Yvette Bernal, Hollie J. Pegram, Mark Przybylowski, Daniel Hollyman, Yelena Usachenko, Domenick Pirraglia, James Hosey, Elmer Santos, Elizabeth Halton, P. Maslak, David A. Scheinberg, Joseph G. Jurcic, Mark Heaney, Glenn Heller, Mark G. Frattini, Michel Sadelain - Blood 2011 被引用: 1,284

  16. Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01

    著者: Jinghua Piao, Susan E. Zabierowski, Brittany N. Dubose, Ellen J. Hill, Monalisa Navare, Nidia Claros, Siera Rosen, Kiran Ramnarine, Callie Horn, Craig Fredrickson, Karen Wong, Brent Safford, Sonja Kriks, Abderrahman El Maarouf, Urs Rutishauser, Claire Henchcliffe, Yongzeng Wang, Isabelle Rivière, Shannon E. Mann, Vladimir P. Bermudez, Stefan Irion, Lorenz Studer, Mark Tomishima, Viviane Tabar - Cell stem cell 2021 被引用: 253

  17. HLA-independent T cell receptors for targeting tumors with low antigen density

    著者: Jorge Mansilla‐Soto, Justin Eyquem, Sascha Haubner, Mohamad Hamieh, Judith Feucht, Noémie Paillon, Andrés E. Zucchetti, Zhuoning Li, Maria Sjöstrand, Pieter L. Lindenbergh, Michelle Sætersmoen, Anton Dobrin, Mathieu Maurin, Archana Iyer, Andreina Garcia Angus, Matthew M. Miele, Zeguo Zhao, Theodoros Giavridis, Sjoukje J. C. van der Stegen, Fella Tamzalit, Isabelle Rivière, Morgan Huse, Ronald C. Hendrickson, Claire Hivroz, Michel Sadelain - Nature Medicine 2022 被引用: 181

  18. Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating

    著者: Mohamad Hamieh, Jorge Mansilla‐Soto, Isabelle Rivière, Michel Sadelain - Cancer Discovery 2023 被引用: 139

  19. Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

    著者: Xiao-Song Zhong, Maiko Matsushita, Jason Plotkin, Isabelle Rivière, Michel Sadelain - Molecular Therapy 2009 被引用: 541

  20. Cooperative CAR targeting to selectively eliminate AML and minimize escape

    著者: Sascha Haubner, Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina, Michael Lopez, Mei Rosa Ng, Kathryn Fraser, Marion Subklewe, Jae H. Park, Xiuyan Wang, Isabelle Rivière, Michel Sadelain - Cancer Cell 2023 被引用: 107

  21. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

    著者: Renier J. Brentjens, Jean‐Baptiste Latouche, Elmer Santos, Francesc Martí, Michael Gong, Clay Lyddane, Philip D. King, Steven M. Larson, Mark A. Weiss, Isabelle Rivière, Michel Sadelain - Nature Medicine 2003 被引用: 662

  22. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

    著者: Kevin J. Curran, Steven Margossian, Nancy A. Kernan, Lewis B. Silverman, David A. Williams, Neerav Shukla, Rachel Kobos, Christopher J. Forlenza, Peter G. Steinherz, Susan E. Prockop, Farid Boulad, Barbara Spitzer, Maria Cancio, Jaap Jan Boelens, Andrew L. Kung, Yasmin Khakoo, Victoria Szenes, Jae H. Park, Craig S. Sauter, Glenn Heller, Xiuyan Wang, Brigitte Sénéchal, Richard J. O’Reilly, Isabelle Rivière, Michel Sadelain, Renier J. Brentjens - Blood 2019 被引用: 279

  23. The promise and potential pitfalls of chimeric antigen receptors

    著者: Michel Sadelain, Renier J. Brentjens, Isabelle Rivière - Current Opinion in Immunology 2009 被引用: 461

  24. Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells

    著者: Sjoukje J. C. van der Stegen, Pieter L. Lindenbergh, Roseanna M. Petrovic, Hongyao Xie, Mame P. Diop, Vera Alexeeva, Yuzhe Shi, Jorge Mansilla‐Soto, Mohamad Hamieh, Justin Eyquem, Annalisa Cabriolu, Xiuyan Wang, Ramzey Abujarour, Tom T. Lee, Raedun Clarke, Bahram Valamehr, Maria Themeli, Isabelle Rivière, Michel Sadelain - Nature Biomedical Engineering 2022 被引用: 71